1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow PF-06263507: new trials by email Literature Review of PF-06263507 trials Research Report on PF-06263507
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of PF-06263507 In Patients With Advanced Solid Tumors PF-06263507 - Neoplasms, Carcinoma, Non Small Cell Lung | Phase 1 | Terminated | Pfizer | 26 | 2013-08-08 | 2019-01-09 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Pfizer (1)
United States (1)